Xiaoting Wu

TL;DR: Surgeons should consider correcting mesenteric malperfusion before undertaking open aortic repair in patients with mesMPS, especially those with acute stroke, gross bowel necrosis at laparotomy, or serum lactate ≥6 mmol/L.

TL;DR: Patients with MPS benefit from a staged approach: upfront endovascular reperfusion followed by aortic OR at resolution of organ failure, as well as the expected mortalities with an “upfront OR for every patient” approach.

TL;DR: Aortic root replacement should be performed for patients with acute type A aortic dissection presenting with an intimal tear at the aorti root, root aneurysm 4.5 cm or greater, connective tissue disease, or unrepairable aortsic valvulopathy, with favorable short- and long-term outcomes.

TL;DR: Clinical genetic testing of known hereditary thoracic aortic dissection genes should be considered in patients with a thoracics with age-of-onset <50 years, family history of thoraco-aortic disease, and no history of hypertension, followed by cascade screening of family members.

TL;DR: Both hemiarch and aggressive arch replacement are appropriate approaches for select patients with ATAAD and Aggressive arch replacement should be considered for an arch aneurysm >4 cm or an intimal tear at the arch unable to be resected by hemi arch replacement, or dissection of the arch branches with malperfusion.